References
- 1. G. Quan, B. Niu, V. Singh, Y. Zhou, C. Wu, X. Pan and C. Wu, Supersaturable solid self-microemulsifying drug delivery system: precipitation inhibition and bioavailability enhancement, Int. J. Nanomed.12 (2017) 8801–8811; https://doi.org/10.2147/IJN.S14971710.2147/IJN.S149717
- 2. N. T. Tung, C. S. Tran, H. A. Nguyen, T. D. Nguyen, S. C. Chi, D. V. Pham, Q. D. Bui and X. H. Ho, Formulation and biopharmaceutical evaluation of supersaturatable self-nanoemulsifying drug delivery systems containing silymarin, Int. J. Pharm.555 (2019) 63–76; https://doi.org/10.1016/j.ijpharm.2018.11.03610.1016/j.ijpharm.2018.11.036
- 3. Z. Q. Chen, Y. Liu, J. H. Zhao, L. Wang and N. P. Feng, Improved oral bioavailability of poorly water-soluble indirubin by a supersaturatable self-microemulsifying drug delivery system, Int. J. Nanomed.7 (2012) 1115–1125; https://doi.org/10.2147/IJN.S2876110.2147/IJN.S28761
- 4. J. M. Landete, Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health, Food Res. Int.44 (2011) 1150–1160; https://doi.org/10.1016/j.foodres.2011.04.02710.1016/j.foodres.2011.04.027
- 5. F. Lei, D. M. Xing, L. Xiang, Y. N. Zhao, W. Wang, L. J. Zhang and L. J. Du, Pharmacokinetic study of ellagic acid in rat after oral administration of pomegranate leaf extract, J. Chromatogr. B796 (2003) 189–194; https://doi.org/10.1016/S1570-0232(03)00610-X10.1016/S1570-0232(03)00610-X
- 6. A. W. R. Hamad, W. M. Al-Momani, S. Janakat and S. A. Oran, Bioavailability of ellagic acid after single dose administration using HPLC, Par. J. Stat.8 (2009) 1661–1664; https://DOI:10.3923/pjn.2009.1661.166410.3923/pjn.2009.1661.1664
- 7. L. Yan, P. Yin, C. Ma and Y. Liu, Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS), Molecules19 (2014) 18923–18935; https://doi:10.3390/molecules19111892310.3390/molecules191118923627145925412040
- 8. J. Wang, D. Zheng, Y. Wang, C. Zhang and X. Sun, Pharmacokinetics study of Erhuang decoction extracts in rats by HPLC-MS/MS, J. Chromatogr. B1059 (2017) 35–42; https://doi.org/10.1016/j.jchromb.2017.05.01910.1016/j.jchromb.2017.05.01928570935
- 9. G. R. Valicherla, M. Riyazuddin, S. Shahi, A. P. Gupta, A. A. Syed, A. Husain and J. R. Gayen, LCESI-MS/MS assay development and validation of a novel antidiabetic peptide PSTi8 in mice plasma using SPE: An application to pharmacokinetics, J. Pharm. Biomed. Anal.180 (2019) 113074; https://doi.org/10.1016/j.jpba.2019.11307410.1016/j.jpba.2019.11307431891874
- 10. V. Ferrone, M. Carlucci, P. Palumbo and G. Carlucci, Bioanalytical method development for quantification of ulifloxacin, fenbufen and felbinac in rat plasma by solid-phase extraction (SPE) and HPLC with PDA detection, J. Pharm. Biomed. Anal.123 (2016) 205–212; https://doi.org/10.1016/j.jpba.2016.01.06210.1016/j.jpba.2016.01.06226898973
- 11. D. Zheng, C. Lv, X. Sun, J. Wang and Z. Zhao, Preparation of a supersaturatable self-microemulsion as drug delivery system for ellagic acid and evaluation of its antioxidant activities, J. Drug Deliv. Sci. Technol.53 (2019) 101209; https://doi.org/10.1016/j.jddst.2019.10120910.1016/j.jddst.2019.101209
- 12. G. Z. Pei, W. Chen, H. Zhang and G. H. Li, Pharmacokinetics of ellagic acid tablets in rabbits, Chin. J. Exp. Tradit. Med. Formulae18 (2012) 136–138; https://doi.org/10.13422/j.cnki.syfjx.2012.12.047
- 13. C. Sun, Y. Gui, R. Hu, J. Chen, B. Wang, Y. Guo, W. Lu, X. Nie, Q. Shen, S. Gao and W. Fang, Preparation and Pharmacokinetics Evaluation of Solid Self-Microemulsifying Drug Delivery System (SSMEDDS) of Osthole, AAPS PharmSciTech19 (2018) 2301–2310; https://doi.org/10.1208/s12249-018-1067-310.1208/s12249-018-1067-329845504
- 14. J. Jinno, N. Kamada, M. Miyake, K. Yamada, T. Mukai, M. Odomi, H. Toguchi, G. G. Liversidge, K. Higaki and T. Kimura, Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs, J. Controll. Release111 (2006) 56–64; https://doi.org/10.1016/j.jconrel.2005.11.01310.1016/j.jconrel.2005.11.01316410029
- 15. H. Mu, R. Holm and A. Müllertz, Lipid-based formulations for oral administration of poorly water-soluble drugs, Int. J. Pharm.453 (2013) 215–224; https://doi.org/10.1016/j.ijpharm.2013.03.05410.1016/j.ijpharm.2013.03.05423578826